Order Article Reprints

Burcher KM, Lantz JW, Gavrila E, Abreu A, Burcher JT, Faucheux AT, Xie A, Jackson C, Song AH, Hughes RT, et al. Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma. Cancers. 2021; 13(22):5733. https://doi.org/10.3390/cancers13225733

Burcher, Kimberly M., Jeffrey W. Lantz, Elena Gavrila, Arianne Abreu, Jack T. Burcher, Andrew T. Faucheux, Amy Xie, Clayton Jackson, Alexander H. Song, Ryan T. Hughes, and et al. 2021. "Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma" Cancers 13, no. 22: 5733. https://doi.org/10.3390/cancers13225733

Burcher, K. M., Lantz, J. W., Gavrila, E., Abreu, A., Burcher, J. T., Faucheux, A. T., Xie, A., Jackson, C., Song, A. H., Hughes, R. T., Lycan, T., Jr., Bunch, P. M., Furdui, C. M., Topaloglu, U., D’Agostino, R. B., Jr., Zhang, W., & Porosnicu, M. (2021). Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma. Cancers, 13(22), 5733. https://doi.org/10.3390/cancers13225733